AMAmy Mistri

Amy Mistri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amy Mistri has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Feasibility Study of Real-Time FMRI with Neurofeedback of Motor Performance in Cerebellar Ataxia

    by Joshua G. Berenbaum, Cherie L. Marvel, Jonathan M. Lisinski, Jeffrey S. Soldate, Owen P. Morgan, Ashley N. Kucharski, Luca P. Lutzel, Jonathan A. Ecker, Laura C. Rice, Amy Mistri, et al.

    Background/Objectives: Neurodegenerative cerebellar ataxia (CA) is a movement disorder caused by progressive cell death in the cerebellum. Motor imagery represents a potential therapeutic tool to improve motor function by “exercising” brain regions associated with movement, without the need for overt activity. This study assessed the feasibility of combining motor imagery with real-time functional magnetic resonance imaging neurofeedback (rt-fMRI-NF) to improve motor function in CA. Methods: During finger tapping conditions, 16 participants with CA pushed a button at the same frequency in time with cross flashing at 1 Hz or 4 Hz, and this information was used to train the model. During motor imagery, participants imagined finger tapping while undergoing rt-fMRI-NF with visual feedback, steering them toward activating their motor circuit. Afterwards, they completed finger tapping again. FMRI analysis compared successful motor imagery trials versus all other imagery events. Brain activity on successful trials was covaried with pre–post rt-fMRI-NF tapping improvement scores. Results: Tapping was more accurate at 1 Hz than 4 Hz, and larger tapping error rates correlated with greater movement impairments. While not significant at the group level, 9 of the 16 participants improved tapping accuracy following rt-fMRI-NF. The size of motor improvements correlated with successful motor imagery activity at 1 Hz in the frontal lobe, insula, parietal lobe, basal ganglia, and cerebellum. Motor improvements were not associated with neurological impairment severity, mood, cognition, or imagery vividness. Conclusions: Feasibility was demonstrated for motor imagery therapy with neurofeedback to potentially improve fine motor precision in people with CA. Brain regions relevant to this process may be considered for targets of non-invasive therapeutic interventions.

  • Open Access

    Early brain changes in Lyme disease are associated with clinical outcomes

    by Cherie L. Marvel, Alison W. Rebman, Kylie H. Alm, Pegah Touradji, Arnold Bakker, Prianca A. Nadkarni, Deeya Bhattacharya, Owen P. Morgan, Amy Mistri, Christopher C. Sandino, et al.

    Lyme disease (LD) is a tick-borne infection due to the bacteria Borrelia burgdorferi. After antibiotic treatment, 10-20% of patients develop post-treatment Lyme disease (PTLD). Neurological symptoms are commonly reported in PTLD. This case-control study tested the hypothesis that brain changes occur in LD and are related to clinical outcomes. A working memory task was administered during functional MRI (fMRI), in conjunction with cognitive assessments and health surveys, to examine brain function and clinical outcomes in people with acute LD disease (n=20; 55.0% male; mean age (range) = 52.3 (26-78)). Assessments were conducted a mean of 15.2 days (range: 1-51) after initial antibiotic treatment [i.e., “baseline”] and again 6 months later. A well-matched group of healthy controls (HC, n=19; 31.6% male; mean age (range) = 46.5 (19-60)) was also assessed 6 months apart. At the 6-month follow-up, the LD group was categorized into those who returned to health (RTH, n=11) and those reporting persistent symptoms (sPTLD, n=9) to determine if early brain changes predicted subsequent outcomes. FMRI data from both LD groups were compared to the HC group. Regions of interest (ROI) values were obtained from the fMRI results and correlated to cognitive performance and symptom survey scores. At baseline, brain activity in the RTH group was significantly increased relative to that of HC. Notably, 64% of the RTH group’s activation clusters were in white matter, confirmed by segmentation analysis. ROIs created from the RTH vs. HC fMRI results, including white matter regions, significantly correlated with better self-reported clinical outcomes. At the 6-month follow-up, most of the RTH group’s activity had normalized relative to HC, and associations between ROI values and clinical outcomes were no longer observed. The sPTLD group showed few fMRI activation differences versus the HC group at either time point, and no significant associations were observed between ROI values and clinical outcomes. Instead, the sPTLD group’s ROI values negatively correlated with cognitive performance at the 6-month follow-up. These results indicate that early brain changes in LD predict future RTH status. Increased brain activation during cognition, including in white matter, may reflect a healing response without which LD patients are more likely to develop PTLD. The observed increased activation in white matter suggests specific mechanisms, such as appropriate astrocyte reactivity, and require further investigation. Understanding how increased brain activity relates to RTH in LD will aid early identification of those vulnerable to developing PTLD and guide treatment.